Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

OTTAWA, September 16 /PRNewswire/ --

- Serious Developers of Telephony and Speech Applications Discover the Latest Benefits, Power and Ease of use of VBVOICE With the Release of VBVoice 5.6.

GREENWICH, Connecticut, HOUSTON, LONDON and VANCOUVER, British Columbia, September 16 /PRNewswire/ --

CHC Helicopter Corporation ("CHC") (TSX: FLY.A, FLY.B) (NYSE: FLI) and First Reserve Corporation ("First Reserve") are pleased to announce that the Plan of Arrangement (the "Arrangement") between 6922767 Canada Inc., an affiliate of funds managed by First Reserve, and CHC was completed today. The Arrangement was overwhelmingly approved by CHC's shareholders at a special meeting held on April 29, 2008, and was approved by the British Columbia Supreme Court on May 1, 2008. Under the Arrangement, 6922767 Canada Inc. acquired all of CHC's outstanding Class A Subordinate Voting Shares and Class B Multiple Voting Shares for cash consideration of CDN$32.68 per share.

ALEXANDRIA, Virginia, September 16 /PRNewswire/ --

- To Provide Clients With Best-in-Class Document Review Services CPA's Discovery Team Passes Stringent Applied Discovery Certification Standards

ALEXANDRIA, Virginia, September 16 /PRNewswire/ --

FRIMLEY, England, September 16 /PRNewswire/ --

- Findings Provide New Evidence for Potential Role of Zometa(R) to Help Reduce the Risk of Breast Cancer Returning

New data from three clinical trials show Zometa(R) (zoledronic acid) reduced the risk of local and distant recurrence in pre- and post-menopausal women with early-stage breast cancer. Investigators reported on the studies this week in Stockholm at the 33rd Annual Congress of the European Society for Medical Oncology (ESMO), the primary European professional organization representing medical oncologists.

NEW YORK, September 16 /PRNewswire/ --

IODA, the global leader in digital distribution, marketing, and technology solutions for the independent music and film industry, and RightsFlow, a provider of licensing and royalty services, announced today that IODA will utilize RightsFlow's Outsourced Music Licensing system ("FLOW") to handle mechanical & DPD licensing. IODA will now offer label clients integrated back-end accounting and business management services for all mechanical licensing needs.

SANTA MONICA, California, September 16 /PRNewswire/ --

- Los Angeles-Based US Renewables Group, Founding Investor of SolarReserve, Participates in US$140 Million Second Round Funding

Today SolarReserve, a developer of utility scale solar power plants, announced that it has closed a second round of funding totaling US$140 million. The financing was led by the renewable energy private equity group within Citi Alternative Investments, Sustainable Development Investments (SDI), and Credit Suisse's Customized Fund Investment Group. Other investors include US Renewables Group, the founding investor in SolarReserve, Good Energies, PCG Clean Energy & Technology Fund and Nazarian Enterprises.